Pilot Study on Non-Invasive Vagus Nerve Stimulation in IBD Remission
The VIBRANT-IBD study is assessing the feasibility of non-invasive vagus nerve stimulation in IBD patients in remission.
Asset / Drug
Drug and asset intelligence for Nurosym with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.